Open AccessShort-term immune response after inactivated SARS-CoV-2 (CoronaVac®, Sinovac) and ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) vaccinations in health care workers
Author(s) -
Watsamon Jantarabenjakul,
Napaporn Chantasrisawad,
Thanyawee Puthanakit,
Supaporn Wacharapluesadee,
Nattiya Hirankarn,
Vichaya Ruenjaiman,
Leilani Paitoonpong,
Gompol Suwanpimolkul,
Pattama Torvorapanit,
Rakchanok Pradit,
Jiratchaya Sophonphan,
Opass Putcharoen
Publication year - 2022
Publication title -
asian pacific journal of allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 33
ISSN - 0125-877X
DOI - 10.12932/ap-250721-1197
Subject(s) - medicine , seroconversion , vaccination , pneumonia , prospective cohort study , regimen , immunology , gastroenterology , antibody
Inactivated SARS-CoV-2 (CoronaVac®, Sinovac, or SV) and ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-Astra Zeneca, or AZ) vaccines have been administered to the health care workers (HCWs).